Found "Public health policy": 1,153 results
Thailand's AMR Strategy: Insights from the 5th National Forum on AMR
Thailand's National Forum on Antimicrobial Resistance (AMR), held every two years, serves as a platform to share knowledge and reinforce the importance of AMR as a global public health threat. Yet AMR rarely commands public attention, compared to non-communicable diseases, despite being associated w
Introduction of early health technology assessment for innovators, clinicians, and funders
Abstract
Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur
Can AI Really Help Us Prevent Diabetes and Hypertension in Thailand?
Non-communicable diseases (NCDs) are often called “silent killers”, but there is nothing silent about their impact. They remain one of the hardest public health battles to win. According to the World Health Organisation (WHO), they cause 43 million deaths worldwide and account for 75% of non-pandemi
From Potential to Practice: AI for Diabetes and Hypertension Prevention in Thailand
Background & RationaleNon-communicable diseases (NCDs) are the leading cause of death worldwide, responsible for 43 million deaths annually and accounting for 75% of all non-pandemic-related mortality globally [1]. Cardiovascular disease, diabetes, cancer, and chronic respiratory conditions drive this burden, yet most health systems remain orie
Natthida Malathong
Natthida Malathong received Bachelor’s in Public Health form major of Public Health, School of Health Science, Mae Fah Luang University in 2015. She start working in HITAP’s research assistant sine 2015 to May 2019 and currently working as a Operations Management Associate
Target product profiles: opportunities and implications for health innovation development–a scoping review
Highlights
By reviewing 120 Target Product Profiles (TPPs), this study identified key aspects of TPP development processes, stakeholder involvement, common themes, major limitations, and priorities for follow-up research.
Health technologies were classified into five categories, and the pr
Combating a Global Public Health Threat: Antimicrobial Resistance – What are we doing?
Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. It occurs when antimicrobials—such as antibiotics, antifungals, antivirals, and antiparasitics—become ineffective against microorganisms like bacteria, fungi, viruses, and parasites. This resistance can le
Early Health Technology Assessment of Non-sputum-based Assays for Screening and Treatment Monitoring in a prospective cohort of pulmonary tuberculosis
Tuberculosis is caused by bacterium called Mycobacterium tuberculosis. It is a significant problem in Thailand as seen that in 2021 Thailand is in the World Health Organization’s list of 30 high-burden countries for tuberculosis. One of the problems about tuberculosis is inaccurate diagnosis due to insufficient sensitivity and specificity of prim
Review of Literature and Information to Support and Pilot testing the Process for Integrating Thai Innovation into Thailand’s Universal Health Coverage System: A Case Study of Advance Wound Dressing from the Thai Innovation List
The development of health and medical innovation is a key national strategy for Thailand under the 13th National Economic and Social Development Plan, which aims to position the country as a high-value medical and wellness hub while reducing dependence on imported medical technologies. The Thai Innovation List was established to promote the commerc
10 / Page